Michael Jolly

Michael Jolly is a skilled Project Manager II at Aktiv Pharma Group. In their current role, Michael oversees a $220M contract for the development and commercialization of a novel 2PAM auto-injector. Prior to this, Michael has held various roles such as Manufacturing Engineer at RAUMEDIC, CAPA Associate II and Manufacturing Supervisor at Baxter International Inc., and Product Development Engineer at Nexans Aerospace USA LLC. Michael possesses a Master of Science in Textile Engineering from North Carolina State University, and a Bachelor of Science in Biomedical/Medical Engineering from the same institution.